41708-93-4

Basic information

• Product Name: Chitotriose 3HCl
• Synonyms: (2R,3R,4R,5R)-2-amino-4-[(2R,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxy-hexanal;Chitotriose 3HCl;Chitotriose Hydrochloride;O-2-Amino-2-deoxy-beta-D-glucopyranosyl-(1-4)-O-2-amino-2-deoxy-beta-D-glucopyranosyl-(1-4)-2-amino-2-deoxy-D-glucose
• CAS NO: 41708-93-4
• Molecular Formula: C18H35N3O13
• Molecular Weight: 501.4828
• Mol File: 41708-93-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 903.7°Cat760mmHg
• Flash Point: 500.3°C
• Appearance: /
• Density: 1.63g/cm³
• PKA: 11.01±0.45(Predicted)
• CAS DataBase Reference: Chitotriose 3HCl(CAS DataBase Reference)
• NIST Chemistry Reference: Chitotriose 3HCl(41708-93-4)
• EPA Substance Registry System: Chitotriose 3HCl(41708-93-4)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 41708-93-4(Hazardous Substances Data)

Usage

General Description

Chitotriose 3HCl is a chemical compound derived from chitin, a natural polymer found in the exoskeletons of insects and the cell walls of fungi. It is composed of three molecules of N-acetylglucosamine linked together. Chitotriose 3HCl has garnered interest in various fields, including biomedicine, agriculture, and biotechnology, due to its potential as a therapeutic agent, biopesticide, and biopolymer. Its unique structure and properties make it a promising candidate for applications such as wound healing, drug delivery, and crop protection. Further research on the synthesis, properties, and applications of Chitotriose 3HCl is ongoing to fully understand its potential and maximize its beneficial uses.

Relevant articles and documents

Enzymatic production of fully deacetylated chitooligosaccharides and their neuroprotective and anti-inflammatory properties

Among several commercial enzymes screened for chitosanolytic activity, Neutrase 0.8L (a protease from Bacillus amyloliquefaciens) was selected in order to obtain a product enriched in deacetylated chitooligosaccharides (COS). The hydrolysis of different chitosans with this enzyme was followed by size exclusion chromatography (SEC-ELSD), mass spectrometry (ESI-Q-TOF), and high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Neutrase 0.8L converted 10?g/L of various chitosans into mostly deacetylated oligosaccharides, yielding approximately 2.5?g/L of chitobiose, 4.5?g/L of chitotriose, and 3?g/L of chitotetraose. We found out that the neutral protease was not responsible for the chitosanolytic activity in the extract, while it could participate in the deacetylating process. The synthesized COS were tested in vitro for their neuroprotective (toward human SH-S5Y5 neurons) and anti-inflammatory (in RAW macrophages) activities, and compared with other functional ingredients, namely fructooligosaccharides.